In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.

Excerpts from recent editorials in the United States and abroad: ___ Jan. 26 The Washington Post on Trump's “energy emergency” Oil and gas production in the United States is hitting record highs, ...

Gov. Mike Braun on Wednesday gave his first State of the State address. Here is the full text of his prepared speech along ...

We present the investment thesis on Perrigo Company plc- a consumer health company which, we believe, is close to an ...

Now that Novo Nordisk is the world’s weight-loss juggernaut, will it have to betray its first patients—type 1 diabetics?

Based on recent policy signals and statements from incoming administration officials, a picture of potential regulatory and policy changes that ...

The individuals or companies within that complicated supply chain are what MCCPDC calls "the middlemen," namely pharmacy benefit managers (PBM ... from manufacturing to prescription delivery.

Read Also: 11 Best 3D Printing and Additive Manufacturing Stocks To Buy ... The company provides health insurance plans, pharmacy benefit management, and wellness programs to individuals ...

Over the past few years, due in part to the proliferation of manufacturing capacity on ... Testing of Plastic Based Material Flooring (PBM Flooring) reads as follows, “Tile Council of North ...

“The good thing about that was it was bipartisan … But if not, we’ll continue to work … So we’ll be able to, I think we’ll be able to make the PBM reform and other things in that bill ...